FSI warns of ‘false positives’ under CARDS
IBD organization expresses suitability concerns with regulator's proposed data-collection system and predicts cost of $250,000 to $1 million — with ongoing maintenance above that.
An organization representing independent broker-dealers doesn't want Finra to include analysis of the suitability of investments in its proposed CARDS data-collection system and warned that the system would impose significant costs on its members.
In a comment letter on Dec. 1, the Financial Service
Learn more about reprints and licensing for this article.